Skip to main content

Table 1 Demographics and baseline characteristics of moderately, severely and critically ill COVID-19 patients

From: An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

  Moderately ill Patients Severely ill patients Critically ill patients Total
(n = 11) (n = 7) (n = 6)
Age (mean), years 80 85.14 73.33 79.83
Sex (%)
 Male 3 (12.5%) 0 3 (12.5%) 6 (25%)
 Female 8 (33.33%) 7 (29.16%) 3 (12.5%) 18 (75%)
Most frequent comorbidities (%)
 Hypertension 8 (33.33%) 3 (12.5%) 3 (12.5%) 14 (58.33%)
 Diabetes mellitus 4 (16.66%) 1 (4.16%) 3 (12.5%) 8 (33.33%)
 Cardiovascular diseases 2 (8.33%) 2 (8.33%) 3 (12.5%) 7 (29.16%)
 COPD 1 (4.16%) 1 (4.16%) 0 2 (8.33%)
 Cancer 0 1 (4.16%) NSCLC 0 1 (4.16%)
  1. Abbreviations: COPD Chronic obstructive pulmonary disease; NSCLC Non-small cell lung cancer